Top Ranked Momentum Stocks to Buy for July 9th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 9th:

Celldex Therapeutics, Inc. (CLDX): This biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.8% over the last 60 days.

Celldex Therapeutics’ shares gained more than 100% over the last one month above the S&P 500’s decline of 2.7%. The company possesses a Momentum Score of A.

GAN Limited (GAN): This provider of enterprise Software-as-a-Service solutions has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.

GAN’s shares gained 41% over the last one month. The company possesses a Momentum Score of A.

Freeport-McMoRan Inc. (FCX): This company that engages in the mining of mineral properties has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Freeport-McMoRan’s shares gained 11.8% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Zacks Top 10 Stocks for 2020

In addition to the stocks discussed above, would you like to know about our 10 finest buy-and-hold tickers for the entirety of 2020?

Last year’s 2019 Zacks Top 10 Stocks portfolio returned gains as high as +102.7%. Now a brand-new portfolio has been handpicked from over 4,000 companies covered by the Zacks Rank. Don’t miss your chance to get in on these long-term buys.

Access Zacks Top 10 Stocks for 2020 today >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research